When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 21 Apr 2025
Last updated: 20 Nov 2024

Summary

Definition

History and exam

Key diagnostic factors

  • blood pressure (BP) >180/120 mmHg
  • presence of risk factors

Other diagnostic factors

  • neurological symptoms
  • cardiac symptoms
  • abnormal cardiopulmonary examination
  • abnormal abdominal examination
  • oliguria or polyuria
  • abnormal fundoscopic examination
  • abnormal neurological examination

Risk factors

  • inadequately treated hypertension
  • chronic kidney disease (CKD)
  • renal artery stenosis
  • renal transplant
  • endocrine disorders with known hypertensive effects
  • pregnancy
  • older age
  • black ethnicity
  • male sex
  • use of sympathomimetic drugs
  • pharmacotherapy with known hypertensive effect
  • obstructive sleep apnoea
  • vasculitis and connective tissue diseases

Diagnostic investigations

1st investigations to order

  • blood chemistry
  • FBC with smear
  • urinalysis with microscopy
  • ECG
  • chest x-ray

Investigations to consider

  • thyroid function tests
  • liver function tests
  • cardiac enzymes
  • N-terminal pro-B-type natriuretic peptide (NT-proBNP)
  • coagulation profile
  • urine or serum pregnancy test
  • urine toxicology screen
  • computed tomography angiography (CTA) scan
  • transthoracic echocardiography (TTE)
  • renal ultrasound with Doppler
  • head CT without contrast
  • head MRI
  • plasma renin activity and aldosterone level
  • spot urine or plasma metadrenaline (metanephrine)
  • 24-hour urine free cortisol
  • sleep study

Treatment algorithm

Contributors

Authors

M. Lee Sanders, PhD, MD

Clinical Associate Professor

Division of Nephrology

University of Iowa

Iowa City

IA

Disclosures

MLS is an author of a reference cited in this topic.

Manish Suneja, MD, FASN, FACP

Clinical Professor

Division of Nephrology

University of Iowa

Iowa City

IA

Disclosures

MS receives royalties from McGraw Hill as the editor of DeGowin’s Diagnostic Examination and is an author of a reference cited in this topic.

Acknowledgements

Dr M. Lee Sanders and Dr Manish Suneja would like to gratefully acknowledge Dr Hector Ventura and Dr Madhavi T. Reddy, previous contributors to this topic.

Disclosures

HV declares that he has no competing interests. MTR is employed by Merck and owns stocks in Merck, and Johnson & Johnson.

Peer reviewers

Aparna Sundaram, DO, MBA, MPH

Physician Consultant

Preventive Medicine

Private Practice

Atlanta

GA

Disclosures

AS declares that she has no competing interests.

Ethan Cumbler, MD

Assistant Professor

Department of Internal Medicine

University of Colorado Health Sciences Center

Denver

CO

Disclosures

EC declares that he has no competing interests.

Michael Schachter, MB, BSc, FRCP

Department of Clinical Pharmacology

St Mary’s Hospital

Imperial College

London

UK

Disclosures

MS declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-248.Full text  Abstract

American College of Obstetricians and Gynecologists. Practice bulletin no. 222: gestational hypertension and preeclampsia. Jun 2020 [internet publication].Full text  Abstract

Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874-2071.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer